Zura Bio Limited
ZURA • NASDAQ
Zura Bio Limited is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Sandeep C. Kulkarni, with a market cap of $562.6M.
CEOSandeep C. Kulkarni
Next Earnings
Upcoming earnings announcement for Zura Bio Limited
Date
Thursday, May 7, 2026 (in a month)
Timing
Before Market Open (6:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.18
Earnings History
Past 11 earnings reports for Zura Bio Limited
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 19, 2026 | Q4 2026 | -$0.49Est: -$0.19 | -157.9% | - | — |  10-K |
| Nov 13, 2025 | Q4 2025 | -$0.21Est: -$0.18 | -16.7% | - | — | — |
| Aug 14, 2025 | Q2 2025 | -$0.17Est: -$0.19 | +10.5% | - | — | 10-Q |
| May 8, 2025 | Q1 2025 | -$0.19Est: -$0.14 | -35.7% | - | — | 10-Q |
| Mar 25, 2025 | Q3 2024 | -$0.08Est: -$0.12 | +33.3% | - | — | 10-Q |
| Nov 7, 2024 | Q4 2024 | -$0.26Est: -$0.14 | -85.7% | - | — | — |
| Aug 13, 2024 | Q2 2024 | -$0.17Est: -$0.15 | -13.3% | - | — | 10-Q |
| May 9, 2024 | Q1 2024 | -$0.02Est: -$0.26 | +92.3% | - | — | 10-Q/A |
| Mar 28, 2024 | Q4 2023 | -$0.30Est: -$0.23 | -30.4% | - | — | 10-K |
| Nov 13, 2023 | Q3 2023 | -$0.18Est: -$0.25 | +28.0% | - | — | — |
| Aug 14, 2023 | Q2 2023 | -$1.31Est: -$0.25 | -424.0% | - | — | — |